The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
A long-acting shot Pfizer got through a buyout of Metsera appeared “slightly inferior” to Lilly’s market-leading Zepbound in a Phase 2 trial, one analyst said.
To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver ...
LOS ANGELES -- The COVID-19 vaccines made by Pfizer and Moderna both require two doses to be administered, several weeks apart, for them to be fully effective. But there has been some scientific ...
Pfizer made one thing clear this week: It's officially back in the obesity race.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results